Prostaglandin E2 content in herniated lumbar disc disease.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8839467.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A prospective series of biochemical assays for prostaglandin E2 content in symptomatic herniated lumbar disc specimens. To help clarify the pathogenesis of lumbar radiculopathy. Three recent studies have shown elevated levels of prostaglandin E2 in intervertebral disc herniations. None of these studies correlated symptoms with prostaglandin E2 levels. Twenty-four disrupted disc samples were purified by a standard solid phase extraction method and analyzed for prostaglandin E2 with an enzyme-linked immunosorbent assay. Clinical and anatomic correlations were sought with analysis of variance and t test. Sequestered discs tended to be associated with a higher prostaglandin E2 content than extruded discs, which in turn, tended to be associated with higher prostaglandin E2 content than protruded ones. A positive straight leg raising test appeared to be associated with a higher prostaglandin E2 content than a negative test. Prostaglandin E2 appears to mediate some of the inflammatory effects of lumbar disc herniation. An intact anulus may provide some protection against this stimulus.
Medical subject headings
- Dinoprostone
- Intervertebral Disc
- Intervertebral Disc Displacement
- Lumbar Vertebrae
Anatomy
- lumbar spine